BACKGROUND AND OBJECTIVE: Cyclo-oxygenase-2 (COX-2, also known as prostaglandin synthase 2) influences carcinogenesis through regulation of angiogenesis, apoptosis, and cytokine expression. COX-2 is encoded by the gene PTGS2. Several studies have suggested that PTGS2 single-nucleotide polymorphisms (SNPs) are involved in gastrointestinal carcinogenesis. In this study, we observed the PTGS2 Val511Ala (5939T/C) polymorphism in the Chinese population for the first time, and investigated whether this polymorphism might contribute to gastric cancer in a case-control study conducted in the Gansu province of China, a high-risk area for gastric cancer. METHODS: We determined the genotypes of 110 gastric cancer patients and 138 controls using polymerase chain reaction (PCR)-based restriction fragment length polymorphism (RFLP) analysis. Data were statistically analyzed using a chi-squared test and a logistic regression model. RESULTS AND CONCLUSION: In our analysis, PTGS2 5939C allele carriers were at increased risk of gastric cancer (odds ratio [OR] 1.742; 95% confidence interval [CI] 1.009, 3.005; p = 0.045). We also found an interaction between Helicobacter pylori infection, a family history of gastric cancer, and presence of the 5939C allele. This study further indicated that H. pylori-positive status and family history jointly contribute to a higher risk of gastric cancer.
BACKGROUND AND OBJECTIVE: Cyclo-oxygenase-2 (COX-2, also known as prostaglandin synthase 2) influences carcinogenesis through regulation of angiogenesis, apoptosis, and cytokine expression. COX-2 is encoded by the gene PTGS2. Several studies have suggested that PTGS2 single-nucleotide polymorphisms (SNPs) are involved in gastrointestinal carcinogenesis. In this study, we observed the PTGS2 Val511Ala (5939T/C) polymorphism in the Chinese population for the first time, and investigated whether this polymorphism might contribute to gastric cancer in a case-control study conducted in the Gansu province of China, a high-risk area for gastric cancer. METHODS: We determined the genotypes of 110 gastric cancerpatients and 138 controls using polymerase chain reaction (PCR)-based restriction fragment length polymorphism (RFLP) analysis. Data were statistically analyzed using a chi-squared test and a logistic regression model. RESULTS AND CONCLUSION: In our analysis, PTGS2 5939C allele carriers were at increased risk of gastric cancer (odds ratio [OR] 1.742; 95% confidence interval [CI] 1.009, 3.005; p = 0.045). We also found an interaction between Helicobacter pyloriinfection, a family history of gastric cancer, and presence of the 5939C allele. This study further indicated that H. pylori-positive status and family history jointly contribute to a higher risk of gastric cancer.
Authors: Patricia G Moorman; John Sesay; Veronica Nwosu; Janet Grubber Kane; Allan René de Cotret; Kendra Worley; Robert Millikan Journal: Cancer Epidemiol Biomarkers Prev Date: 2005-12 Impact factor: 4.254
Authors: N Uemura; S Okamoto; S Yamamoto; N Matsumura; S Yamaguchi; M Yamakido; K Taniyama; N Sasaki; R J Schlemper Journal: N Engl J Med Date: 2001-09-13 Impact factor: 91.245
Authors: Henry J Lin; Karen M Lakkides; Temitope O Keku; Srinivasa T Reddy; Andrew D Louie; Irving H Kau; Haiyan Zhou; Jason S Y Gim; Hoang L Ma; Carl F Matthies; Aihua Dai; Hsiao-Fen Huang; Alicia M Materi; Jesse H Lin; Harold D Frankl; Eric R Lee; Steven I Hardy; Harvey R Herschman; Brian E Henderson; Laurence N Kolonel; Loïc Le Marchand; R Michael Garavito; Robert S Sandler; Robert W Haile; William L Smith Journal: Cancer Epidemiol Biomarkers Prev Date: 2002-11 Impact factor: 4.254
Authors: Robert Sitarz; Roos J Leguit; Wendy W J de Leng; Mirjam Polak; Folkert M Morsink; Onno Bakker; Ryszard Maciejewski; G Johan A Offerhaus; Anya N Milne Journal: Mod Pathol Date: 2008-02-29 Impact factor: 7.842
Authors: Grace Min Yi Tan; Chung Yeng Looi; Keith Conrad Fernandez; Jamuna Vadivelu; Mun Fai Loke; Won Fen Wong Journal: Sci Rep Date: 2015-06-16 Impact factor: 4.379